A Multicentre, Retrospective-prospective Real-world Study: to Evaluate the Effectiveness and Safety of Vorasidenib in Patients With Isocitrate Dehydrogenase IDH1/2 Mutant Grade 2 Astrocytoma or Oligodendroglioma (VICTORIA Study)
Clinical trial NCT06969352 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06969352
- Sponsor
- Servier (Tianjin) Pharmaceutical Co. LTD.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2025-09-02
- Primary completion
- 2028-04-01
- Enrollment
- 62
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.